Intellectual Property India Publishes Patent Application for 'Solid Dispersion Comprising Amorphous 2-[3-[4-(Lh-Indazol-5- Ylamino)Quinazolin-2-Yl]Phenoxy]-Npropan-2-Yl-Acetamide' Filed by Kadmon Corporation, Llc

MUMBAI, India, Aug. 8 -- Intellectual Property India has published a patent application (202517042371 A) filed by Kadmon Corporation, Llc, Bridgewater, U.S.A., on May 1, for 'solid dispersion comprising amorphous 2-[3-[4-(lh-indazol-5- ylamino)quinazolin-2-yl]phenoxy]-npropan-2-yl-acetamide.'

Inventor(s) include Regev, Galit; and Schueller, Olivier.

The application for the patent was published on Aug. 8, under issue no. 32/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure relates to a solid dispersion comprising amorphous belumosudil. The present disclosure also provides pharmaceutical dosage forms comprising the solid dispersion comprising amorphous belumosudil as an active pharmaceutic...